Molecular pharmacological characterization and association testing of human GIPR genetic variants with follow-up analysis in mice shows that β-arrestins regulate GIPR signalling and thereby strongly contribute to metabolic outcomes.
- Hüsün S. Kizilkaya
- Kimmie V. Sørensen
- Mette M. Rosenkilde